SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001847903-23-000099
Filing Date
2023-05-22
Accepted
2023-05-22 07:06:42
Documents
15
Period of Report
2023-05-22
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cnta-20230522.htm   iXBRL 8-K 40799
2 EX-99.1 a051923fasttrackdesignatio.htm EX-99.1 13628
7 GRAPHIC letterheada.jpg GRAPHIC 60436
  Complete submission text file 0001847903-23-000099.txt   340444

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20230522.xsd EX-101.SCH 2751
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20230522_def.xml EX-101.DEF 17043
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20230522_lab.xml EX-101.LAB 34206
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20230522_pre.xml EX-101.PRE 18407
9 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20230522_htm.xml XML 15187
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 23942415
SIC: 2834 Pharmaceutical Preparations